Randomized clinical trial to assess the efficacy and safety of a strategy for primary prevention of cardiovascular disease in patients with inflammatory rheumatic diseases based on the use of carotid ultrasound.

Status

Not yet recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-521086-28-00

Enrollment

1250

Registered

2025-10-03

Start date

Unknown

Completion date

Unknown

Last updated

2025-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CHRONIC INFLAMMATORY RHEUMATIC DISEASE: rheumatoid arthritis or psoriatic arthritis or axial spondyloarthritis or systemic lupus erythematosus

Brief summary

occurrence of a major cardiovascular event: acute myocardial infarction or stroke, hospital admission for unstable angina, arterial revascularization for peripheral artery disease, death due to CV disease

Detailed description

individualized appearance of each of the cardiovascular events that make up the primary endpoint

Interventions

DRUGATORVASTATIN AND AMLODIPINE

DRUGROSUVASTATIN AND EZETIMIBE

DRUGBEMPEDOIC ACID

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
occurrence of a major cardiovascular event: acute myocardial infarction or stroke, hospital admission for unstable angina, arterial revascularization for peripheral artery disease, death due to CV disease	—

Secondary

Measure	Time frame
individualized appearance of each of the cardiovascular events that make up the primary endpoint	—

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026